Research Article
Quality of Sulfadoxine-Pyrimethamine Given as Antimalarial Prophylaxis in Pregnant Women in Selected Health Facilities in Central Region of Ghana
Table 4
Recorded peak responses of five replicate injections and calculated percentage dissolution of sulfadoxine and pyrimethamine in Drugs I and III.
| | Average peak area of sulfadoxine (mV) | Percentage of sulfadoxine dissolved (%) | Average peak area of pyrimethamine (mV) | Percentage of pyrimethamine dissolved (%) |
| Drug I | | | | | 1 | 6892774 | 59.42 | 90182 | 20.20 | 2 | 7076779 | 61.00 | 114852 | 25.74 | 3 | 6991092 | 60.27 | 90667 | 20.31 | 4 | 7017232 | 60.49 | 105682 | 23.67 | 5 | 6981546 | 60.18 | 110563 | 24.76 | 6 | 6889575 | 59.39 | 115472 | 25.86 | Drug III | | | | | 1 | 10898130 | 93.94 | 358382.5 | 80.27 | 2 | 10516241 | 90.65 | 347357 | 77.80 | 3 | 10790608 | 93.02 | 305035 | 68.32 | 4 | 10811924 | 93.20 | 314093.5 | 70.35 | 5 | 10679338 | 92.06 | 298327.6 | 66.82 | 6 | 10592611 | 91.31 | 306223.3 | 68.59 |
|
|
(mV): millivolts.
|